Key result
Endomyocardial biopsy confirms cardiac amyloid deposits across five patients, predominantly identifying AL-amyloidosis.
Why the study?
Unexplained abnormal thickening of the interventricular septum with rapidly progressive heart failure may be caused by cardiac amyloid deposits detectable by endomyocardial biopsy.
Case Report (n=5)
Answers are grounded in this paper and cite their sources.
Supports biopsy for amyloid subtyping in select phenotypes; leaves open its broader diagnostic role pending prospective data.
In four patients with unexplained, abnormal thickening of the interventricular septum as demonstrated by echocardiography, right ventricular endomyocardial biopsy revealed unexpected cardiac amyloid deposits that resulted in increased myocardial thickness and rapidly progressive heart failure. Light microscopically, amyloid was observed in the subendocardial layer, interstitium, and walls of the intramural arterioles. Electron-microscopically, the amyloid fibrils were adjacent to the basement membranes of the heart muscle cells and the vascular smooth muscle cells. Immunohistochemical typing with specific antibodies against different amyloid fibril proteins on glutaraldehyde-fixed paraffin sections revealed different amyloid types. In two patients with generalized idiopathic amyloidosis and in two others with amyloidosis in multiple myeloma, the A-lambda form was diagnosed. In a fifth patient, AA-amyloidosis was found in familial Mediterranean fever with cardiac manifestation without thickening of the interventricular septum. The amyloid deposits were located almost exclusively within the walls of the myocardial arterioles. The amount of amyloid as observed in the myocardial biopsies correlates with the rapidly progressive cardiac failure. It is suggested that in patients with abnormal thickening of the interventricular septum of unknown origin the diagnosis should be clarified by endomyocardial biopsy.
No takes yet. Share an insight, caveat, or question.
Frenzel et al. (1986) conducted a case report in Cardiac amyloidosis (n=5). Endomyocardial biopsy was evaluated on Cardiac amyloid deposits identified by light microscopic, ultrastructural, and immunohistochemical studies. Endomyocardial biopsy revealed cardiac amyloid deposits in 5 patients, identifying A-lambda amyloidosis in 4 patients with septal thickening and AA-amyloidosis in 1 patient with FMF.
Synapse has enriched 10 related papers. Consider them for comparative context: